A biotechnology company in Cambridge, Massachusetts, says it is engineering cells inside a living human body in hopes of one day ending genetic diseases.
The company boasted that recent trials were performed on DNA inside of a person rather than the typical method of extracting the DNA first.
‘A major milestone in gene editing.’
Trending: Ms. Rachel backs Macklemore, demands that white celebrities speak out
Clustered Regularly Interspaced Short Palindromic Repeats is technology used to selectively modify the DNA of living organisms. A company called Prime Medicine believes it has a more efficient way of accurately editing DNA than the CRISPR method — called Prime Editing — working directly in the body.
The company says the first disorder it is tackling with live trials is an illness called Wilson disease.
Wilson disease is a rare disorder where excess copper is abnormally
Continue reading
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!